ZLN005

ZLN005 是新型过氧化物增殖激活受体协同激活子 (PGC-1α) 激活剂。
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
Free Sample (0.1-0.5 mg) | Apply now | ||
10 mM * 1 mL in DMSO | ¥605 | In-stock | |
10 mg | ¥550 | In-stock | |
50 mg | ¥2000 | In-stock |
生物活性 | ZLN005 is a potent activator of peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α)[1]. | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IC50 & Target | Peroxisome proliferator-activated receptor-γ coactivator-1α[1] | ||||||||||||||||
体外研究 (In Vitro) | ZLN005 (2.5-20 μM; 24 hours ) activates AMPK in a dose-dependent manner[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot Analysis[1]
| ||||||||||||||||
体内研究 (In Vivo) | ZLN005 (15 mg/kg; p.o.; per day for 4 weeks) decreases random blood glucose and fasting blood glucose levels over 4 weeks compared with lean mice[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||
分子量 | 250.34 | ||||||||||||||||
Formula | C₁₇H₁₈N₂ | ||||||||||||||||
CAS 号 | |||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 22 mg/mL (87.88 mM; Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
*以上所有助溶剂都可在 MCE 网站选购。 | ||||||||||||||||
参考文献 |